why biotechs need to worry about generics, too

This is what Alan is on about and why the pharmas MUST have our product(S)

"If you?re able to keep someone off for one or two years, and you?re $1 billion [in sales] a year, who?s going to sneeze at $2 billion? If you?ve got a smaller company, and they hit the $500 million mark, that?s huge for them."

Read the full story....

http://blogs.wsj.com/venturecapital/2011/06/14/why-biotechs-need-to-worry-about-generics-too/